chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Presented with fever, hematuria; Covid + in ED;dx with Covid PNA; tx with Vit C, Zithromax, maxipime, Vit D3, Veletri, steroids, zinc, rocephin, remdisivir, doxycycline, baricitnib; initially maintained sats on room air; increasing hypoxia appx day 5 of hosp; started remdesivir; to ICU Day 13, high flow O2: 9.16 remains in ICU; FiO2 requirements slightly improved; Despite maximum effort, the patient's respiratory status continued to worsen in which he developed a left pneumothorax in which a chest tube was placed. developed a right pneumothorax in which in another chest tube was placed on the right side.  Transitioned over to comfort care; expired 10/5/21.
Muscle and joint pain about 2 to 4 weeks after Twinrix injection #2.  Sx started September 2008 and persist.  Sx have improved slightly.
Patient developed a fever; Vaccine location: Left leg; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 2-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Aug2022 at 12:00 as dose 1, single (Lot number: FT9142) at the age of 2 years intramuscular, in left leg for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (non-serious) with onset 12Aug2022 at 12:00, outcome "unknown", described as "Vaccine location: Left leg"; PYREXIA (non-serious) with onset 13Aug2022 at 17:00, outcome "not recovered", described as "Patient developed a fever". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia.  Additional information: It was reported that the patient developed a fever in the afternoon on 13Aug2022. Fever got to 102 Fahrenheit and was treated with Tylenol; the patient still had temperature in the morning on 16Aug2022. Tylenol did decrease the temperature. There was nothing known about patient's allergies. The patient did not receive any other vaccine in four weeks. The patient did not have Covid prior to vaccination. The patient was not tested for Covid post vaccination. AE did not result in physician office visit or emergency room visit. The reporter classified the event as non serious.
Patient came to pharmacy to get his second Moderna COVID-19 vaccine but were given Pfizer covid-19 vaccine
EXTENSIVE AREA OF REDNESS, WARMTH AND SWELLING, NON TENDER ,COVERING THE LATERAL ASPECT OF THE LEFT THIGH
Initial and follow up information has been received from a Registered Nurse concerning a female who on the afternoon of 08-Sep-2006 was vaccinated IM with her first dose of HPV vaccine (yeast), lot #653650/0702F, and experienced flu-like symptoms. No medical attention was sought. Additional information has been requested. This is in follow-up to report (s) previously submitted on 12/14/2006.  Within a day or two, the patient recovered. Follow up information indicated the patient received her second dose of GARDASIL and had no adverse experience. Additional information is not expected.
About 4 days after getting the shot I got really sick and starting vomiting and had diarrhea. My skin and whites of my eyes turned yellow. I went to the doctor and was told my liver enzymes were over 4,000. My physician had me sent to the hospital where they immediately started medications to lower my enzymes. It was not working, and after 6 hours they were still high. I was taken to surgery and given a liver transplant. I was hospitalized for 3 weeks.
Pt was pale and light headed after the shots. He passed out 2 x's that evening but had not ate and he played baseball. (Pt was worked up and afraid of shot prior to getting it).
This case was reported by a physician via call center representative and described the occurrence of urticaria in a 70-year-old female patient who received SHINGRIX. Previously administered products included methotrexate. On 29th January 2018, the patient received SHINGRIX. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced urticaria. The patient was treated with Antihistamines. On an unknown date, the outcome of the urticaria was unknown. It was unknown if the reporter considered the urticaria to be related to SHINGRIX. Additional details were provided as follows: Initially spoke to physician via click to chat and then asked if call could be made regarding possible adverse event. The adverse event collected via phone. The patient stopped methotrexate for two months after their underlying condition of urticaria resolved. The patient received SHINGRIX on 29th January 2018 during this time. After receiving SHINGRIX the patient experienced another flare of urticarial at an unknown point in time. The physician reported that no other vaccines on that day, and only mentioned that the patient was on Antihistamines. The physician did not want to be data bank when being asked questions regarding adverse event, so the physician was transferred to a vaccine specialist before all questions could be asked. The physician was not asked for permission to be contacted by Safety.
NOT FEELING WELL; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received ustekinumab (solution for injection, route of admin not reported, batch number: UNKNOWN expiry: UNKNOWN) dose, frequency, and therapy dates were not reported for an unspecified indication. The patient received covid-19 vaccine  (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced not feeling well. The action taken with covid-19 vaccine  was not applicable; and action taken with ustekinumab was not reported. The outcome of not feeling well was not reported. This report was non-serious.
This spontaneous report as received from a 67 year old female physician referred to himself with allergies to hay fever and no pertinent medical history. On an unknown date in December 2009, the patient was vaccinated with a dose of ZOSTAVAX (dose, frequency and lot number not provided). Concomitant therapy included unspecified hormone patch for menopause and multivitamin. On an unknown date the patient experienced shingles approximately in October 2014 "over this past weekend". The patient described the vesicles as "3-4 dermatome distribution; near the left clavicle down the left chest then on the back of the left side of neck coming down lateal to clavicle". The patient prescribed herself VALTREX which she started taking 06-OCT-2014. At the time of reporting, the patient was not recovered from shingles. Additional information has been requested.
The first injection was in my right arm.  It felt sore and then I kept waiting for all the soreness to go away.  However, I still have soreness that won't go away.  I did not tell my doctor because I kept thinking that it would eventually go away.  I have been to chiro/rehab and still won't go away.  My 2nd dose got in my left arm and I started showing signs of arthritis on my left side.  I have numbness and tingling that go all the way down to my left arm and feel it in my thumb and pointer.  I again waited for that to dissipate but would not.  My doctor sent me to have a nerve test done and showed I have no nerve damage.  Again I have been using chiro/rehab and the pain and symptoms have subsided but still have not gone away completely.  I have not injured my neck so there should not be a reason for me to have inflamed arthritis in that area but started happening after I received my 2nd shot in that same left side of my arm.
Pt  developed chest pains and heart racing  that night along with high fever 102 with very bad headache.  Chills and fever and weakness latest through Friday afternoon  Fever started to go down Friday afternoon and weakness improved. Headache remains strong
Pt vaccinated with DTP experienced a high pitched no-stop scream X 2-3Hrs. Mom says no temp.
VACCINE ADMINISTERED AFTER 6 HOUR EXP. EXPIRED AT 4PM AND GIVEN AT 5:20P
2 mo old PT recd 1st DTP/Hibtiter immun; appr. 1 mo later PT was hospitalized for Hib meningitis (culture results unknown); hospital summary requested;
Patient receive vaccine on 11/12/2012, came back 11/15/2012 with her upper arm swollen, redness, itch, very warm. Advised pt to take TYLENOL to see if it help.
Carryover bilateral tinnitus from first and second COVID-19 vaccinations on 03/08/2021 and 03/29/2021 (see VAERS report numbers 388804 and 480345). Tinnitus has never resolved and intensifies with each vaccine dose.
Felt hot and sweaty for a few minutes. Walked over to restroom, felt dizzy and fainted for about a minute or so I was told.  I called my primary care provider?s office and I was advised to go to ER which I did. ER records list the cause of the syncope as ?vaccine reaction.?
pt recv vax;febrile sz;T of 103; seen in er; no grand mal; staring limp on 4mar;
Woke up at 8am with high heart rate over 100, occurred throughout sleep up to 110 bpm and continues to be over 100 during inactivity.  Oxygen is good and fatigue is moderate. Not short of breath but have sore throat. Not an allergic reaction. Heart rate has came down by 4pm but is still high 90s.
Half an hr post inject, could not raise arm above head; Condition lasted until 24 hrs post inject; Had a dime-sized bruise @ the inject site in addition to finger swelling & joint aches in the arm that was injected;
Case number PHEH2014US025135, is an initial spontaneous report from a nurse on 09 Dec 2014. This report refers to a 47-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 21 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
My thyroid condition worsened up despite taking the levothyroxine. I started to feel worse condition of thyroid that I got after the 1st shot. I started to feel all swollen, gained weight  like crazy again. All my bones are achy. I feel chronically tired. Highly irritated. No energy. Memory get worse. Losing hair worse that it was before. Voice became harsh and, when I feel stressed, something inside my throat feels like its choking me.
Heart rate of 125 while sleeping, low-grade fever (99.8), skin felt like fire to the touch, chills, body aches, nausea, ball ody parts felt heavy, everything that touched my body hurt, room temperature water felt like it was burning my skin
no symptoms after waiting 30 minutes,  then mild fatigue 3 hours later then woke from sleep  at 11pm  with a rapid heart rate about 100/minute, widespread numbness and tingling around mouth, chin, arms and calves.  called 911  BP was 135/77 98 pulox 68 pulse. Numerous episodes similar happened  since usually at night.  PCP advised allergist related to COVID reaction. ECHO,EKG  were ok.  adjusted meds to see if related and no change. also had very bloodshot eyes ,rash on legs and more need for Xopenex inhaler.   Addressed with pulmonologist as well.
I had a sore arm for about a day after receiving the vaccine. I tested positive for COVID-19 on 12/08/2022. I contacted my doctor and got a prescription for molnupiravir. I tolerated the medication without any complications. Since receiving the vaccine, I have trouble with my arthritis and my asthma. I was diagnosed with pneumonia on 02/04/2023 and was hospitalized for eight days. As of today, I continue to have problems with my asthma.
Headache, fever, hot flashes, Whole Body stiffness @ 2100 pm.
Symptoms: sudden onset sensation of intoxication, brain fog, feeling off balance and bouts of dizziness/vertigo. Parasthesia, diminished sensation and tingling in feet and mid-back, weakness and absence of involuntary reflex on left side of body. Diagnosis of possible MS/demyelinating disease 4 months after 3rd shot/booster.
Patient with no previous oxygen requirement prior to hospitalization.  Patient developed myalgias, arthralgias ,fevers approximately day 1 after vaccine booster obtained on November 16.  Patient continued to worsen clinically with myalgias arthralgias coughing.  Approximately 5 days after receiving Covid developed worsening shortness of breath.  Patient presented to the hospital Patient with no previous oxygen requirement.  Patient developed myalgias arthralgias fevers approximately day 1 after vaccine booster obtained on November 16.  Patient continued to worsen clinically with myalgias arthralgias coughing.  Approximately 5 days after receiving Covid developed worsening shortness of breath.  Patient presented to the hospitalon 11/29 was found to have diffuse groundglass opacities on chest CT.  Patient developed increasing oxygen requirements ultimately intubated and is now in the ICU.  All work-up as far as connective tissue disease has been negative.  Patient currently on high-dose steroids.
Following administration patient began experiencing intense heat ensation and flushed face.  Patient stated that he previously experienced urticaria due to unknown etiology which was relieved by  diphenhydramine liquid. Patient denied breathing difficulty, weakness, dysphagia or itching.  Patient given diphenhydramine 25mg PO x2.  Over time patient with increased skin redness, urticaria noted on body trunk.  Patient experiencing cough reflex and states itching over all body. EMS activated to clinic and patient transferred to local ED.
Injection site remains swollen and painful a week after the vaccine was given, and now experiencing a well defined rash that is large, oval, raised and red, with clear edge to it around the area of the injection site. It is warm to the touch and remains swollen.
40 hours after receiving vaccine, awoke with night sweats.  Felt find otherwise. Went back to sleep and fine in morning.; This is a spontaneous report from a non-contactable consumer. This 67-year-old male consumer (patient) received BNT162B2 (lot number=EL3249) on 21Jan2021 11:30 AM at single dose on Left arm for covid-19 immunization. Medical history was hypertension, chronic atrial fib. Known allergies to contrast media (hives), possibly penicillin (rash as child). No other vaccine in four weeks. 40 hours after receiving vaccine, awoke with night sweats on 23Jan2021 03:00 AM. Felt find otherwise. Went back to sleep and fine in morning. No treatment. Outcome of the event was recovered. No covid prior vaccination. No covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.
At 5:22 pm patient reported to nurse that she was feeling "sleepy", lightheaded, and "cold" after she  recieved her first dose of Pfizer BioNTech COVID-19 vaccine EUA. Viitals taken every 5 minutes. Patient  then reports that she is feeling heavyness in her body, nausea, and started to feel "warm coming from  the inside." 5: 45pm Administered 50 mg of Benadryl by mouth. Patient initially declined meds.  Monitored patient for one hour. Patient was alert and oriented and left clinic with her friend.
Upper L thigh area with 7cm x 6cm erythema noted. Warm to touch. Instructed to monitor.
all died within the 5 weeks after there first shot; This is spontaneous report from a contactable consumer. This the third case out of six cases.   An elderly male patient of unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date of 2021 as single dose for covid-19 immunisation. The patient medical history and the patient's concomitant medications were not reported. On unknown date the patient died within the 5 weeks after the first vaccination. It was not reported if an autopsy was performed. The patient was in a residential home with 5 other elderly residents. He/she died in sleep.  Information related Lot/Batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021617030 same reporter, same vaccine, same adverse event, different patient.; Reported Cause(s) of Death: Unknown cause of death
12/15/2020 Strong diarrhea 1x.  12/16/2020 felt 'not right'. temperature 99.3,99.5. took tylenol. headache. Temp went down. Felt weak.  12/17/2020  tylenol, nausea, light headache 12/18/2020 Felt the 'most weak'.
sz pt had hydrocephalus w/shunt in place; ER MD adm pt shunt wasn't working properly required surgerry next day; PMD recommends DT only;
Patient presented to the ED and was subsequently hospitalized on 3/2/21 within 6 weeks of receiving COVID vaccination. Diagnosis was acute on chronic respiratory failure. Patient presented to the ED and was subsequently hospitalized again on 3/30/21 for pulmonary edema.
Hypersensitivity reaction developing rash 48 hours after vaccine administration. No other signs and symptoms noted. Clinically healthy.
After leaving the office, the pt experienced dizziness, seeing dark, muscle pains starting on the way home. Numbness of arms and legs, couldn't lift legs, started dragging legs. Pt was then hunched over and unable to walk. Pt was feeling better and came to school. On 3/27/00 he was sent home from school as he was hunched over and unable to walk.
Headache, nausea, chills, fatigue, low-grade temperature. Most symptoms  lasted for around 24 hours. Fatigue last of the longest and took about two days to dissipate.  I treated with Pepto, Tylenol,  ibuprofen, a lot of fluids and rest. Onset of headache was roughly 1 hour after the injection nausea followed closely at about two hours in. All other symptoms occurred within 30 minutes of onset of nausea.
Extremely intense headache for 24 hours.  Headache not a sufficient term for the pain, really.  Treated with Tylenol.  Also, injection site had red blotches, swelled up, and very tender to the touch.
I started coming down with Covid-19 symptoms on Dec 26, 2022, and tested positive with a home test on Dec 27.
3/29/2021   Ms. Funez was observed post Covid-19 immunization for 45 minutes  .  During the observation period, she experienced an adverse reaction with the following symptoms:  dizziness.   Assessment : Time of assessment Alert and oriented.   Actions taken:  Vitals sign taken at 1707 BP- 131/95, P- 87, O2- 100, T- 98.3       Medications administered: No medication administered.   Disposition: Reports no further symptoms of adverse reaction after observation for 45 minutes. Discharged home.     Immunizations Administered    Name Date Dose VIS Date Route   Pfizer COVID-19 Vaccine 3/29/2021  4:48 PM 0.3 mL 12/11/2020 Intramuscular
Client reported prior to vaccination, that it is common for him to become faint and possibly "pass out" when receiving injections, having blood draws completed, and IVs started.  Verified that client was feeling well and had eaten breakfast and was hydrated prior to injection.  Client sitting in chair and tolerated injection well.  About 5 minutes after injection given, client reported that he was feeling faint.  Client was clammy and pale, and lost consciousness for about 30 seconds. Wife present and held his head and stood next to him in the chair.  Client did not fall, and stayed seated in the chair.  He slowly regained consciousness, and when able to sit and speak, client was offered water, which he accepted.  VS collected - BP sitting in RUE - 108/78, P - 64, R - 16, O2 sats - 96%.  Client started to regain color, and report that he was feeling better.   Granola bar offered and client ate.  Wife reported that this is a common event for client, when having blood drawn, IVs started, or injections given.  Client states that he has "passed out many times before." Client stayed seated in chair, with RN and wife in room with him.  By 0945, client states that he was feeling "back to normal."  No s/s of allergic reaction.  Wife to drive home and stay with husband for the rest of the day.  Discussed s/s of allergic reaction, and other s/s that require immediate medical attention.  Wife and client verbalized understanding.
6-7pm after 4pm injection sore arm. 9pm sore arm, slight headache. Day 2 morning: headache, fatigue, sore arm, diarrhea. Day 2 evening: chills, joint pain, fatigue, sore arm, headache. Day 3: diarrhea, slight fatigue.
Pt states arm is painful at all times and pain increases upon movement. The pain is not improving and the shot was given 18 days prior.
Sl. raised, pink, warm area Lt upper arm 5cm central darker red area. Lt upper arm 2cm area, sore and itchy.
Patient called the health department to report later in the afternoon/early evening on 12/13/2022 she experienced lightheadedness and some mild vertigo that came and went. She also reported feeling jittery and anxious for a couple of hours. She denies any past history of becoming symptomatic after other vaccines.   On 12/14/2022 she rested most of the day but reported infrequent lightheadedness and mild vertigo.  On 12/15/2022 she denied feeling unwell but had not moved around much that day.  I advised patient that is she was still experiencing this symptoms on 12/16/2022 to reach out to her primary card physician. Patient verbalized understanding.
During the night after I received vaccination I began running a fever, headache, and ache in back basically hurt all over. Temp is 99.5
I have had Tinnitus (Ringing Ears) for several years but it has generally been mild and tolerable. A couple of days after the first dose I noticed my ears were ringing more then usual. It has been very annoying and bothersome. I am very concerned if they will continue ringing this loudly. I am not going to get the 2nd dose. I am very much hoping as the vaccine wears off that my ears will get better.
pt recv vax 22OCT98 & devel an inj site rxn characterized by a 12cm by 6cm rectangular shaped area of redness, swelling, itching & a raised rash w/raised border;
poss viral infect, apnea inc, bradycardia inc, lymphocytosis occurring w/in 8hr of vax;tx sepsis eval;ATB & other med given;
Multiple bruises noted on patient in the morning. By the evening, bruises increasing in number and severity.  Noted petechia on lower extremities and trunk.  Notified MD via telephone.  Pt assessed by pediatrician and hematologist next day.  Admitted to hospital for abnormal labs, low platelets and WBCs.  Platelet count critical low value.  Monitored and discharged following day with diagnosis of idiopathic thrombocytopenia purpura (ITP).
pt stated that on the same day she started having stomach cramping and diarrhea.  Next day pt woke up with head congestion and coughing with major drip of mucus going down her throat.  She is also weak and dizzy.  Three days later pt had tingling in upper lip and gum.  Fourth day pt still had congestion and still had the tingling in lips and gums.  Pt spoke w/ PCP on call and was told to rest.  Fifth day pt still had all of the same symptoms and then she had developed a light vibrating sensation on her right side on the inside area around the breast.  Pt had this symptom for the next  2 days.  She went to her Pulmonologist which did not find anything wrong w/ her lungs and thought she may have hurt her back.  Pt started feeling better but is still very weak.  Pt stated about a week later she developed a headache that she could not get rid of.  On 2/8/2021 pt still has headache.  On 2/9/2021 she woke up weak and dizzy and just dont feel well.  Pt is concerned about taking her 2nd vaccine.